244 related articles for article (PubMed ID: 11209987)
1. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
2. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
Juhan-Vague I; Alessi MC
Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
[TBL] [Abstract][Full Text] [Related]
3. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].
Banfi C; Mussoni L; Tremoli E
Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793
[TBL] [Abstract][Full Text] [Related]
4. Fat cell function and fibrinolysis.
Alessi MC; Morange P; Juhan-Vague I
Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
[TBL] [Abstract][Full Text] [Related]
5. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
Mavri A; Alessi MC; Juhan-Vague I
J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
8. Visceral fat as a determinant of fibrinolysis and hemostasis.
Mertens I; Van Gaal LF
Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
[TBL] [Abstract][Full Text] [Related]
9. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
Yamamoto K; Takeshita K; Kojima T; Takamatsu J; Saito H
Cardiovasc Res; 2005 May; 66(2):276-85. PubMed ID: 15820196
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
[TBL] [Abstract][Full Text] [Related]
11. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
12. Hypofibrinolysis and insulin-resistance.
Juhan-Vague I; Vague P
Diabete Metab; 1991 May; 17(1 Pt 2):96-100. PubMed ID: 1936490
[TBL] [Abstract][Full Text] [Related]
13. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
15. [From fibrinogen to fibrin and its dissolution].
Juhan-Vague I; Hans M
Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
[TBL] [Abstract][Full Text] [Related]
16. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
17. Hypofibrinolysis and the insulin resistance syndrome.
Vague P; Raccah D; Scelles V
Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S11-5. PubMed ID: 7550531
[TBL] [Abstract][Full Text] [Related]
18. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
19. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
20. Functional role of the fibrinolytic system in development of adipose tissue.
Lijnen HR
Verh K Acad Geneeskd Belg; 2009; 71(3):101-13. PubMed ID: 20088250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
